2014
DOI: 10.1016/j.crad.2014.01.010
|View full text |Cite
|
Sign up to set email alerts
|

The prognostic significance of MRI-detected extramural venous invasion in rectal carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

7
63
1

Year Published

2014
2014
2021
2021

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 101 publications
(71 citation statements)
references
References 23 publications
7
63
1
Order By: Relevance
“…Several reports have shown that pathologic EMVI correlates significantly with metachronous metastases [9,10] and we believe that MRI-detected EMVI would also be a risk factor for metachronous distant tumour spread. Recently, Bugg et al showed that MRI-detected EMVI are associated with an increased metachronous metastases within 1 year of diagnosis [33]. Second, not every patient in this study underwent liver MRI or FDG-PET/CT, and there is a possibility that we missed some metastases.…”
Section: Discussionmentioning
confidence: 84%
“…Several reports have shown that pathologic EMVI correlates significantly with metachronous metastases [9,10] and we believe that MRI-detected EMVI would also be a risk factor for metachronous distant tumour spread. Recently, Bugg et al showed that MRI-detected EMVI are associated with an increased metachronous metastases within 1 year of diagnosis [33]. Second, not every patient in this study underwent liver MRI or FDG-PET/CT, and there is a possibility that we missed some metastases.…”
Section: Discussionmentioning
confidence: 84%
“…Postsurgical recurrence of rectal cancer was also shown to differ according to MRI-predicted EMVI status in one study: 3-year recurrence-free survival of 35% in patients with EMVI-positive findings on MRI compared with 74% in EMVI-negative patients (60). Tumor extension into the extramural veins may provide a pathway of hematogenous dissemination of the tumor cells and would explain the reason why EMVI is a risk factor for synchronous or metachronous metastasis in patients with rectal cancer (6162). EMVI is currently not considered for TNM staging of a rectal cancer, one reason for which is presumably the highly variable reported prevalence (9–61% (59)), which may indicate inconsistent recognition and reporting of the findings.…”
Section: Elaboration On the Reporting Items Formats And Their Clinimentioning
confidence: 99%
“…Furthermore, the presence of EMVI has a relative risk of 3.7 for the development of systemic recurrence when detectable on preoperative MRI scanning[15]. The role of EMVI in directing treatment is relatively new and not well established.…”
Section: Introductionmentioning
confidence: 99%